Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 27

    Gilead offers to test Ebola drug remdesivir as new coronavirus treatment in China

    Gilead offers to test Ebola drug remdesivir as new coronavirus treatment in China

    Medical Dialogues Bureau1 Feb 2020 12:38 PM IST
    Gilead Sciences Inc said it was also expediting laboratory testing of the antiviral drug, remdesivir, against samples of the new coronavirus, which...
    Eugia Pharma gets USFDA nod for generic drug: Aurobindo Pharma

    Eugia Pharma gets USFDA nod for generic drug: Aurobindo Pharma

    MD bureau1 Feb 2020 10:15 AM IST
    New Delhi: Aurobindo Pharma on Friday said its joint venture firm Eugia Pharma Specialities has received approval from the US health regulator to...
    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    Medical Dialogues Bureau1 Feb 2020 9:45 AM IST
    Drug firm Jubilant Life Sciences on Friday reported a 23.97 per cent fall in consolidated net profit at Rs 203.38 crore for the third quarter ended...
    USFDA cautions Aurobindo Pharmas oral solids formulation facility of regulatory action

    USFDA cautions Aurobindo Pharma's oral solids formulation facility of regulatory action

    MD bureau31 Jan 2020 1:29 PM IST
    NEW DELHI: Drug firm Aurobindo Pharma on Thursday reported that the US health regulator has cautioned that its oral solids formulation manufacturing...
    Cipla Foundation sets up dedicated state-of-the-art chemistry laboratory at IISER Pune

    Cipla Foundation sets up dedicated state-of-the-art chemistry laboratory at IISER Pune

    MD bureau31 Jan 2020 1:26 PM IST
    Pune: In continuance of its efforts to advance quality education and promote industry-academia collaboration, the Cipla Foundation, the social...
    GSK launches Iodex UltraGel

    GSK launches Iodex UltraGel

    Medical Dialogues Bureau31 Jan 2020 1:23 PM IST
    New Delhi – GSK announced the launch of Iodex UltraGel, a new age clinically proven gel-based body pain solution. Backed by science, the new...
    Yamma buys $200-mln minority stake in Turkish drug maker Sanovel

    Yamma buys $200-mln minority stake in Turkish drug maker Sanovel

    Medical Dialogues Bureau30 Jan 2020 4:15 PM IST
    Istanbul: Luxembourg-based Yamma Investments agreed to buy a 30% stake in Turkish generic drug maker Sanovel for $200 million, the target company's...
    Mercks antibacterial med Dificid Gets FDA nod in Pediatric Indication

    Merck's antibacterial med Dificid Gets FDA nod in Pediatric Indication

    Medical Dialogues Bureau30 Jan 2020 3:50 PM IST
    Merck & Co., Inc announced that the FDA has granted approval to its new drug application ("NDA") and a supplemental NDA (sNDA) for its...
    Beijing drug store fined whooping $434,530 for hiking price of masks

    Beijing drug store fined whooping $434,530 for hiking price of masks

    Medical Dialogues Bureau30 Jan 2020 3:12 PM IST
    BEIJING: - A drug store in Beijing will be fined 3 million yuan ($434,530) for hiking the price of face masks by almost six times the online price...
    US offers 30 Billion US dollars more market to domestic pharma cos

    US offers 30 Billion US dollars more market to domestic pharma cos

    Medical Dialogues Bureau30 Jan 2020 3:10 PM IST
    Mumbai : Domestic pharma companies have the potential to grow their revenue from the US by almost five times at around USD 30 billion from USD 6.5...
    Alembic Pharmaceuticals gets USFDA Approval for Azithromycin Tablets

    Alembic Pharmaceuticals gets USFDA Approval for Azithromycin Tablets

    Medical Dialogues Bureau29 Jan 2020 1:25 PM IST
    Alembic Pharmaceuticals announces USFDA Final Approval for Azithromycin Tablets USP, 600 mg. Alembic Pharmaceuticals Limited (Alembic) has announced...
    Cipla gets USFDA EIR for Invagen manufacturing facility

    Cipla gets USFDA EIR for Invagen manufacturing facility

    Medical Dialogues Bureau29 Jan 2020 12:57 PM IST
    New Delhi: Homegrown pharma major Cipla on Tuesday said it has received a report from the US health regulator indicating closure of the inspection at...
    PrevNext

    Popular Stories

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    KKRs Envision Healthcare hires bank to explore debt restructuring: Report

    KKR's Envision Healthcare hires bank to explore debt restructuring: Report

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Coronavirus Impact: Indian Pharma Exports to miss 22 Billion target, says Pharmexcil

    Coronavirus Impact: Indian Pharma Exports to miss 22 Billion target, says Pharmexcil

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok